Fjarde Ap Fonden Medtronic PLC Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Medtronic PLC stock. As of the latest transaction made, Fjarde Ap Fonden holds 341,079 shares of MDT stock, worth $28.7 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

341,079

Previous 354,379 3.75%

Holding current value

$28.7 Million

Previous $30.9 Million 0.57%

% of portfolio

0.31%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$76.84 - $91.03 $1.02 Million - $1.21 Million	-13,300 Reduced 3.75%	341,079 $30.7 Million
Q1 2024 Apr 25, 2024	BUY	$82.84 - $88.09 $405,916 - $431,641	4,900 Added 1.4%	354,379 $30.9 Million
Q4 2023 Feb 14, 2024	SELL	$69.43 - $83.43 $2.21 Million - $2.65 Million	-31,792 Reduced 8.34%	349,479 $28.8 Million
Q3 2023 Oct 23, 2023	SELL	$78.22 - $90.4 $516,252 - $596,640	-6,600 Reduced 1.7%	381,271 $29.9 Million
Q2 2023 Aug 02, 2023	SELL	$79.47 - $91.38 $2.37 Million - $2.72 Million	-29,800 Reduced 7.13%	387,871 $34.2 Million
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $598,416 - $683,124	-7,800 Reduced 1.83%	417,671 $33.7 Million
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $2.06 Million - $2.37 Million	27,000 Added 6.78%	425,471 $33.1 Million
Q2 2022 Aug 11, 2022	BUY	$87.4 - $113.09 $4.2 Million - $5.43 Million	48,000 Added 13.7%	398,471 $35.8 Million
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $4.45 Million - $4.98 Million	-44,291 Reduced 11.22%	350,471 $38.9 Million
Q4 2021 Feb 15, 2022	SELL	$99.53 - $127.75 $686,757 - $881,475	-6,900 Reduced 1.72%	394,762 $40.8 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $1.8 Million - $1.99 Million	-14,700 Reduced 3.53%	401,662 $50.3 Million
Q2 2021 Aug 12, 2021	SELL	$118.19 - $131.5 $1.19 Million - $1.33 Million	-10,100 Reduced 2.37%	416,362 $51.7 Million
Q1 2021 May 17, 2021	BUY	$111.18 - $119.74 $1.86 Million - $2 Million	16,700 Added 4.08%	426,462 $50.4 Million
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $422,394 - $491,988	4,200 Added 1.04%	409,762 $48 Million
Q3 2020 Nov 13, 2020	BUY	$90.13 - $108.78 $1.23 Million - $1.49 Million	13,700 Added 3.5%	405,562 $42.1 Million
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $1.35 Million - $1.65 Million	16,000 Added 4.26%	391,862 $35.9 Million
Q1 2020 May 11, 2020	SELL	$72.92 - $121.3 $1.44 Million - $2.4 Million	-19,800 Reduced 5.0%	375,862 $33.9 Million
Q4 2019 Feb 10, 2020	BUY	$104.49 - $114.54 $585,144 - $641,424	5,600 Added 1.44%	395,662 $44.9 Million
Q3 2019 Oct 31, 2019	SELL	$98.02 - $111.18 $1.64 Million - $1.86 Million	-16,691 Reduced 4.1%	390,062 $42.4 Million
Q2 2019 Jul 17, 2019	SELL	$84.15 - $99.38 $1.14 Million - $1.35 Million	-13,600 Reduced 3.24%	406,753 $39.6 Million
Q1 2019 Apr 29, 2019	BUY	$82.45 - $93.79 $8.44 Million - $9.6 Million	102,362 Added 32.19%	420,353 $38.3 Million
Q4 2018 Jan 31, 2019	SELL	$85.8 - $99.49 $3.78 Million - $4.39 Million	-44,100 Reduced 12.18%	317,991 $28.9 Million
Q3 2018 Nov 09, 2018	SELL	$85.91 - $99.17 $1.43 Million - $1.66 Million	-16,700 Reduced 4.41%	362,091 $35.6 Million
Q2 2018 Jul 12, 2018	SELL	$77.48 - $87.83 $198,116 - $224,581	-2,557 Reduced 0.67%	378,791 $32.4 Million
Q1 2018 May 07, 2018	BUY	$76.55 - $87.26 $149,195 - $170,069	1,949 Added 0.51%	381,348 $30.6 Million
Q4 2017 Feb 12, 2018	BUY	$76.93 - $83.5 $4.39 Million - $4.76 Million	57,020 Added 17.69%	379,399 $30.6 Million
Q3 2017 Nov 07, 2017	BUY	$77.71 - $84.6 $107,939 - $117,509	1,389 Added 0.43%	322,379 $25.1 Million
Q2 2017 Aug 08, 2017	BUY	N/A	320,990	320,990 $28.5 Million

Others Institutions Holding MDT

# of Institutions

2,283

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $112B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account